Xoma reported $4.26M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Agenus AGEN:US $ 21.38M 4.73M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Ardelyx ARDX:US $ 17.31M 2.81M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Chimerix CMRX:US 4.89M 479K
Curis CRIS:US $ 4.33M 267K
Eli Lilly And LLY:US $ 1.58B 107.8M
Emergent Biosolutions EBS:US $ 82.1M 9.1M
Epizyme EPZM:US $ 32.79M 1.1M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Life Technologies LIFE:US $ 2.59M 200K
Macrogenics MGNX:US $ 17.16M 1.93M
Novartis NOVN:VX 3.6B 109M
Novartis NVS:US 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Prothena PRTA:US 11.96M 923K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Teva Pharmaceutical Industries TEVA:US 864M 32M
Xoma XOMA:US $ 4.26M 328K
YTE INCY:US $ 190.7M 21.84M